Proactive Investors - Run By Investors For Investors

Proactive Investors One2One Investor Forum - London

Anglo Asian Mining PLC | Open Orphan | Silence Therapeutics PLC

The presentations will start at 6:00pm and finish at approx 8:00pm. After the presentations are complete the directors will also be available to take questions during a free canapé and wine reception. Details on the presenting companies can be found below.

 

This event is suitable for the following:

Sophisticated & private investors, private client brokers, fund managers, financial institutions, hedge funds, buy & sell side analysts and journalists.

 

The event is not suitable for people pursuing commercial opportunities.

Anglo Asian Mining PLC

RSS Portfolio

1560950140_Anglo_Asian_Mining_PLC.png


Anglo Asian Mining PLC is quoted on AIM (ticker - AAZ) and has a portfolio of gold, copper and silver exploration and production assets in Azerbaijan. The Company’s key operations span three contract areas in Azerbaijan covering 1,062 square kilometres. Three additional contract areas covering 900 square kilometres are held in territories occupied by Armenia. The Company started to produce gold in May 2009 at its open pit mine at Gedabek in Western Azerbaijan. Gadir, an underground mine 700 meters from the Gedabek open pit, commenced production in 2015. Ugur, a newly discovered gold ore deposit located three kilometres from the Company’s processing facilities at Gedabek commenced production in September 2017.

The Company has a second underground mine in the 300 square kilometre Gosha contract area located 50 kilometres north-west of Gedabek. Gosha is currently being operated as a small, high grade, underground gold mine.

EPIC: AAZ
Market: ISE
52-week High/Low: 132.20p / 38.20p
Market Cap: 146.99M


View full company profile

Open Orphan

RSS Portfolio

1557485123_open_orphan.png


Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug focused pharma services company by a management team with extensive industry and financial expertise. Open Orphan is listed on both the London and Dublin stock exchanges.

The company is divided into three divisions;

  • Open Orphan Services
  • Open Orphan Virtual Rep
  • Open Orphan Health Data
     
EPIC: ORPH
Market: AIM
52-week High/Low: 8.15p / 6.55p
Market Cap: 19.52M


View full company profile

Silence Therapeutics PLC

RSS Portfolio

1508314642_sil.png


Silence Therapeutics develops a new generation of medicines by harnessing the body’s natural mechanism of RNA interference, or RNAi, within its cells.

Our proprietary technology can selectively inhibit any gene in the genome, specifically silencing the production of disease-causing proteins. Using our enabling delivery systems, we have achieved an additional level of specificity by delivering our therapeutic RNA molecules exclusively to target cells. Silence’s proprietary RNA chemistries and delivery systems are designed to improve the stability of our molecules and enhance effective delivery to target cells, providing a powerful modular technology well suited to tackle life-threatening diseases.

EPIC: SLN
Market: AIM
52-week High/Low: 175.00p / 40.00p
Market Cap: 109.92M


View full company profile

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use